340B

News

AbbVie has opened a new front in the pharma industry's efforts to reform the 340B drug discounting programme for safety net hospitals in the US.

News

An appeals court in the US has said AbbVie, AstraZeneca, Novartis, and Sanofi must defend claims they defrauded federal and state governments.

News

Hospitals that challenged a US pilot of a new rebate model for medicines provided to low-income people have won another legal victory.

News

A federal judge in the US has granted a restraining order that will stop the 340B rebate model from launching as planned on 1st January.

Market Access

Today's podcast with Entity Risk's Neal Masia includes insights on the 340B Program, PBMs, and risk-based contracts.

News

Battle lines are being drawn on 340B rebates as AbbVie loses a bid to block a Mississippi law seeking to retain discounts for contract pharmacies.